Evidence map›Paper›PMID 42130070›Full record

ArticleNucleic acids research2026

Phosphorylation by CDK1 switches the function of the human SLX4 SAP domain from DNA binding to MUS81 binding.

Sarah Scaglione, Pierre-Henri Gaillard

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sarah ScaglioneAix Marseille Univ, CNRS, Inserm, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Equipe Labellisée LIGUE 2025, 13009 Marseille, France.ORCID 0000-0001-6705-5645
Pierre-Henri GaillardAix Marseille Univ, CNRS, Inserm, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Equipe Labellisée LIGUE 2025, 13009 Marseille, France.ORCID 0000-0003-0781-0826

Funding

Agence Nationale de la Recherche ANR-24-CE12-0391-01Fondation pour la Recherche Médicale 2020Fondation pour la Recherche Médicale AAPFondation pour la Recherche Médicale EQU202003010245Fondation pour la Recherche Médicale EquipeFondation pour la Recherche Médicale FRMInstitut National Du Cancer 2019-152Institut National Du Cancer 2023Institut National Du Cancer INCa-18352Institut National Du Cancer INCa-PLBioInstitut National Du Cancer PLBioLigue Nationale Contre le Cancer 2025Ligue Nationale Contre le Cancer EquipeLigue Nationale Contre le Cancer LabéliséeLigue Nationale Contre le Cancer LIGUE
6 · The paper itself

Abstract

SLX4 is a scaffold protein pivotal in genome protection mechanisms ranging from homologous recombination and interstrand cross-link (ICL) repair to mechanisms that deal with challenged DNA replication. Many of human SLX4 functions rely on its ability to interact and control the XPF-ERCC1, MUS81-EME1, and SLX1 structure-specific endonucleases. Interaction with MUS81 relies on the conserved SAP domain of SLX4. Since the same domain in yeast Slx4 orthologs does not interact with Mus81, we investigated whether human SLX4 SAP might have retained some ancestral MUS81-independent functions. We show that human SLX4 SAP binds DNA with a preference for branched structures such as Holliday junctions. We further discovered that phosphorylation of SLX4 SAP by CDK1, which promotes interaction with MUS81, inhibits DNA binding. We identified separation of function mutants that impair either DNA or MUS81 binding. Binding to MUS81 is required in response to ICL-inducing agents, methyl methanesulfonate (MMS), TOP1, and PARP inhibition. Instead, DNA binding is required in response to ICL-inducing agents and MMS but not after TOP1 or PARP inhibition. Our work indicates that phosphorylation by CDK1 acts as a regulatory switch between DNA binding and MUS81-dependent functions of SLX4, to accommodate specific DNA lesions or secondary structures.

Indexed as

CDC2 Protein KinaseDNADNA-Binding ProteinsEndonucleasesRecombinasesHumansPhosphorylationProtein BindingProtein DomainsCDC2 Protein KinaseCDK1 protein, humanDNADNA-Binding ProteinsEndonucleasesMUS81 protein, humanRecombinasesSLX4 protein, human

Identifiers

PMID42130070
PMCPMC13171448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.